2.1100
04-September-25 13:45:00
15 minutes delayed
Stocks
-0.1900
-8.26%
Today's range
2.0900 - 2.2500
ISIN
N/A
Source
NASDAQ
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
29 Sep 2022 05:00:01 By Nasdaq GlobeNewswire